Gepirone Extended-Release: First Approval.
Keam SJ.
Drugs · review; journal article · DOI 10.1007/s40265-023-01975-5 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för gepirone hydrochloride. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
13 hitsGepirone hydrochloride: a novel antidepressant with 5-HT1A agonistic properties.
Kaur Gill A, Bansal Y, Bhandari R, Kaur S, Kaur J, Singh R, Kuhad A, Kuhad A.
Drugs Today (Barc) · review; journal article · DOI 10.1358/dot.2019.55.7.2958474Relapse prevention with gepirone ER in outpatients with major depression.
Keller MB, Ruwe FJ, Janssens CJ, Sitsen JM, Jokinen R, Janczewski J.
J Clin Psychopharmacol · clinical trial; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/01.jcp.0000150221.53877.d9Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE, Franznick DA, Hollander SB, Fava M.
J Clin Psychiatry · clinical trial; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.4088/jcp.v65n0807Effects of food on the bioavailability of gepirone from extended-release tablets in humans: results of two open-label crossover studies.
Fabre LF, Timmer CJ.
Curr Ther Res Clin Exp · research-article; journal article · DOI 10.1016/j.curtheres.2003.09.012Effect of food on the bioavailability of gepirone in humans.
Tay LK, Sciacca MA, Sostrin MB, Farmen RH, Pittman KA.
J Clin Pharmacol · clinical trial; randomized controlled trial; journal article · DOI 10.1002/j.1552-4604.1993.tb04715.xGepirone hydrochloride: preclinical pharmacology and recent clinical findings.
Yevich JP, Eison MS, Eison AS, Taylor DP, Yocca FD, VanderMaelen CP, Riblet LA, Robinson DS, Roberts DL, Temple DL.
Prog Clin Biol Res · comparative study; clinical trial; review; randomized controlled trial; journal articleBehavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
Barrett JE, Witkin JM, Mansbach RS, Skolnick P, Weissman BA.
J Pharmacol Exp Ther · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0022-3565(25)24321-xA study of the effects of buspirone, BMY 13805, and 1-PP on dopaminergic metabolism in the nucleus accumbens using in vivo voltammetry in freely moving rats.
Louilot A, Le Moal M, Simon H.
Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/0024-3205(86)90015-9Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.
Caccia S, Fong MH, Guiso G.
Xenobiotica · research support, non-u.s. gov't; journal article · DOI 10.3109/00498258509045035Characterization of polymorphism of gepirone hydrochloride.
Behme RJ, Brooke D, Farney RF, Kensler TT.
J Pharm Sci · journal article · DOI 10.1002/jps.2600741004The effects of buspirone, BMY-13805 and 1-(2-pyrimidinyl)-piperazine on cat spinal reflexes.
Matheson GK, Eison MS.
Methods Find Exp Clin Pharmacol · research support, non-u.s. gov't; journal articleComparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug.
McMillen BA, Mattiace LA.
J Neural Transm · research support, non-u.s. gov't; journal article · DOI 10.1007/bf01248997